Anika Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Anika Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Anika Therapeutics Inc.
Rating: 1.789097125
Author: Trendlyne DVM scores

Momentum Trap

about

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides ...

14.91 -0.43 (-2.80%)

89.45% Gain from 52W Low

71,159

XNAS Volume

XNAS 15 May, 2026 5:30 PM (EDT)

Low Financial Strength

22.2 / 100

Expensive Valuation

28.3 / 100

Technically Bullish

70.4 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 17%

2 analysts

Anika Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Anika Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides ...

89.45% Gain from 52W Low

SWOT Analysis

Anika Therapeutics Inc Live Price Chart